Immunology | Penn Today

Improving T-cell responses to vaccines

Penn Vet and Penn Medicine researchers have modified mRNA vaccines to include the cytokine IL-12 and improve T-cell responses which could improve the body’s ability to fight infections.

3 min. read

From no hope to a potential cure for a deadly blood cancer

Carl June of the Perelman School of Medicine discusses multiple myeloma.

The human brain as though it is being scanned.

Dual-target CAR T-cell therapy slows growth of aggressive brain cancer

Researchers from Penn Medicine have demonstrated encouraging tumor reductions rarely seen in recurrent glioblastoma following phase I clinical trials.

3 min. read

When measles struck, a surge of parents stepped up to vaccinate their children

According to a poll from the Annenberg Public Policy Center, 83% of Americans say that the benefits of the MMR vaccine for children outweigh any potential or perceived risk.

FDA significantly limits access to COVID-19 vaccines

Susan Ellenberg of the Perelman School of Medicine wants to avoid a situation where people who don’t fall into a “recommended” category couldn’t get a vaccine if they wanted it.

3-D rendering of chimeric antigen receptor T (CAR-T) cell therapy, a treatment for a variety of cancers

Enhanced CAR T cell therapy offers new strategy for lymphoma

A new study from Penn Medicine marks a significant development in the ongoing evolution of CAR T cell therapy, as a novel cytokine-enhanced CAR T that has been tested in patients with blood cancer shows robust response rates.

2 min. read

Top row: Dennis Discher, Michael Correa-Jones, and Cherie Kagan. Bottom row: Sophie Rosenfeld and Susan Weiss.

Five Penn faculty elected to the American Academy of Arts and Sciences

Dennis E. Discher, Michael Jones-Correa, Cherie R. Kagan, Sophia Rosenfeld, and Susan R. Weiss are being recognized for their contributions to engineering, political science, history, and biology.

3 min. read

RFK Jr. and the CDC disagree on a major autism study

Paul Offit of the Perelman School of Medicine says that recent claims about a link between vaccines and autism are illustrative of a fast and loose relationship with scientific fact.

Scientists hope far-UVC light could help stop the next airborne pandemic before it starts

Scott Hensley of the Perelman School of Medicine says that with more human infections by bird flu comes more chance of human-to-human transmission.

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

A preclinical study from the Perelman School of Medicine and Penn Medicine’s Abramson Cancer Center that combines RAS inhibition and immunotherapy shows promise for future clinical trials in pancreatic cancer treatment strategies.

1 min. read

Filters

Improving T-cell responses to vaccines

From no hope to a potential cure for a deadly blood cancer

Dual-target CAR T-cell therapy slows growth of aggressive brain cancer

When measles struck, a surge of parents stepped up to vaccinate their children

FDA significantly limits access to COVID-19 vaccines

Enhanced CAR T cell therapy offers new strategy for lymphoma

Five Penn faculty elected to the American Academy of Arts and Sciences

RFK Jr. and the CDC disagree on a major autism study

Scientists hope far-UVC light could help stop the next airborne pandemic before it starts

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer